diethylnitrosamine has been researched along with pioglitazone in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, YT; Leng, XS; Li, T; Lin, XH; Zhao, JM | 1 |
| Guo, YT; Leng, XS; Li, T; Lin, XH; Zhao, JM; Zhu, JY | 1 |
| Borbath, I; Horsmans, Y; Leclercq, I; Moulin, P; Sempoux, C | 1 |
| Arora, G; Baumert, TF; Erstad, DJ; Fuchs, BC; Ghoshal, S; Hoshida, Y; Lanuti, M; Li, S; Masia, R; Sojoodi, M; Tanabe, KK | 1 |
4 other study(ies) available for diethylnitrosamine and pioglitazone
| Article | Year |
|---|---|
Peroxisome proliferator-activated receptor gamma ligands suppress liver carcinogenesis induced by diethylnitrosamine in rats.
Topics: Alkylating Agents; Animals; Anticarcinogenic Agents; Chromans; Diethylnitrosamine; Gene Expression; Glutathione Transferase; Hypoglycemic Agents; Immunohistochemistry; Ligands; Liver Neoplasms; Male; Pioglitazone; PPAR gamma; Rats; Rats, Wistar; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Troglitazone | 2004 |
[Pexoxisome proliferator-activated receptor gamma ligands suppress liver carcinogenesis induced by diethylnitrosamine in rats].
Topics: Animals; Antineoplastic Agents; Chromans; Diethylnitrosamine; Ligands; Liver Neoplasms, Experimental; Male; Pioglitazone; PPAR gamma; Rats; Rats, Wistar; Rosiglitazone; Thiazolidinediones; Troglitazone | 2005 |
The PPARgamma agonist pioglitazone inhibits early neoplastic occurrence in the rat liver.
Topics: 2-Acetylaminofluorene; Animals; Anticarcinogenic Agents; Apoptosis; Blotting, Western; Carcinogens; Carcinoma, Hepatocellular; Cell Proliferation; Chemoprevention; Diethylnitrosamine; Immunohistochemistry; Ki-67 Antigen; Liver Neoplasms; Male; Pioglitazone; PPAR gamma; Rats; Rats, Wistar; Thiazolidinediones | 2007 |
Pioglitazone Reduces Hepatocellular Carcinoma Development in Two Rodent Models of Cirrhosis.
Topics: Adiponectin; AMP-Activated Protein Kinases; Animals; Carcinoma, Hepatocellular; Choline; Diet, High-Fat; Diethylnitrosamine; Disease Models, Animal; Disease Progression; Hypoglycemic Agents; Liver Cirrhosis; Liver Neoplasms; Male; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; Pioglitazone; Rats; Rats, Wistar; Signal Transduction | 2019 |